PARADIGM DIAGNOSTICS, INC.

Profile

Company Names

PARADIGM DIAGNOSTICS, INC.

Addresses

445 N. 5TH STREET, SUITE 300, PHOENIX, AZ 85004

Phone Numbers

602-850-7000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$10,979,989.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2016-11-16 
$10,979,989.00 
$12,500,000.00 
$1,520,011.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
ARMKNECHT 
DIRECTOR
CAREFX CORP   |  PARADIGM DIAGNOSTICS, INC.
GRACE 
 
COLON 
DIRECTOR
INTREXON CORP   |  INCARDA THERAPEUTICS, INC.   |  PERCEPTIMED, INC.   |  COCOON BIOTECH INC.   |  PARADIGM DIAGNOSTICS, INC.   |  VOYAGER THERAPEUTICS, INC.
ERIN 
 
CURLEY 
DIRECTOR
PARADIGM DIAGNOSTICS, INC.
DAVID 
 
MALLERY 
EXECUTIVE OFFICER, DIRECTOR
PARADIGM DIAGNOSTICS, INC.
RODNEY 
 
MARKIN 
DIRECTOR
TRANSGENOMIC INC   |  PERCEPTIMED, INC.   |  PODPONICS, INC.   |  TROVAGENE, INC.   |  PARADIGM DIAGNOSTICS, INC.   |  CARDIFF ONCOLOGY, INC.
SCOTT 
 
MORRIS 
EXECUTIVE OFFICER
TRILOGY INTERNATIONAL PARTNERS LLC   |  PROFESSOR CONNORS, INC   |  BLUESHIFT INTERNATIONAL MATERIALS, INC.   |  GASTECHNO ENERGY + FUELS (USA) LLC   |  TRILOGY INTERNATIONAL NEW ZEALAND LLC   |  PARADIGM DIAGNOSTICS, INC.   |  TRILOGY INTERNATIONAL PARTNERS INC.   |  AQUA SCIENCES, INC.   |  EXPERIENCE CISSE, LTD.   |  HIVE BRANDS HOLDINGS, INC.   |  LML ESTATE MANAGEMENT, LLC   |  AQUARIAN SPACE INC.   |  CHARTA HEALTH, INC.
DAVID 
 
NEAL 
EXECUTIVE OFFICER
PARADIGM DIAGNOSTICS, INC.   |  FRONTIER FIVE ELMS III, LP   |  BOULDIN CORP   |  NOCIMED, INC.   |  SC CAPITAL 1 LLC   |  ACLARION, INC.   |  GRAVITAS MANAGEMENT, L.L.C.   |  V360 HOLDINGS LLC SERIES DCP2302A   |  V360 HOLDINGS LLC SERIES 2302B   |  V360 HOLDINGS LLC SERIES 2303A   |  V360 HOLDINGS LLC SERIES 2304A   |  V360 HOLDINGS LLC SERIES 2304B   |  V360 HOLDINGS LLC SERIES 2305A   |  V360 HOLDINGS LLC SERIES 2305B   |  V360 HOLDINGS LLC SERIES 2311B   |  V360 HOLDINGS LLC SERIES 2308A   |  V360 HOLDINGS LLC SERIES 2311A   |  V360 HOLDINGS LLC SERIES DCP 2401A   |  V360 HOLDINGS LLC SERIES 2311D   |  V360 HOLDINGS LLC SERIES 2312A   |  V360 HOLDINGS LLC SERIES 2306B   |  V360 HOLDINGS LLC SERIES 2308B   |  V360 HOLDINGS LLC SERIES 2306A   |  V360 HOLDINGS LLC SERIES 2404A   |  V360 HOLDINGS LLC SERIES DCP 2406B   |  V360 HOLDINGS LLC SERIES DCP 2405A   |  V360 HOLDINGS LLC SERIES DCP 2406A   |  V360 HOLDINGS LLC SERIES DCP 2406C   |  V360 HOLDINGS LLC SERIES DCP 2407A   |  V360 HOLDINGS LLC SERIES DCP 2409A   |  V360 HOLDINGS LLC SERIES DCP 2410B   |  V360 HOLDINGS LLC SERIES DCP 2410A   |  V360 HOLDINGS LLC SERIES DCP 2411A   |  V360 HOLDINGS LLC SERIES DCP 2410C   |  V360 HOLDINGS LLC SERIES DCP 2412A   |  V360 HOLDINGS LLC SERIES DCP 2503A   |  V360 HOLDINGS LLC SERIES DCP 2503B   |  V360 HOLDINGS LLC SERIES 2502A   |  V360 HOLDINGS LLC SERIES DCP 2501B   |  V360 HOLDINGS LLC SERIES DCP 2501A   |  V360 HOLDINGS LLC SERIES DCP 2501C   |  V360 HOLDINGS LLC SERIES DCP 2505A   |  V360 HOLDINGS LLC SERIES DCP 2505B   |  DUKE CAPITAL PARTNERS 2505C, A SERIES OF V360 HOLDINGS, LLC   |  DUKE CAPITAL PARTNERS 2506A, A SERIES OF V360 HOLDINGS, LLC   |  DUKE CAPITAL PARTNERS 2506D, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2506C, A SERIES OF V360 HOLDINGS, LLC   |  DUKE CAPITAL PARTNERS 2506B, A SERIES OF V360 HOLDINGS, LLC   |  DUKE CAPITAL PARTNERS 2509A, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2508B, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2508A, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2509C, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2509B, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2507A, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2510B, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2510A, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2510C, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2512B, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2512A, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2511B, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2511A, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2510D, A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2511C, A SERIES OF V360 HOLDINGS LLC A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2512C, A SERIES OF V360 HOLDINGS LLC A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2601A A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2602A A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2603A A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2603B A SERIES OF V360 HOLDINGS LLC   |  DUKE CAPITAL PARTNERS 2603C A SERIES OF V360 HOLDINGS LLC
CAREY 
 
NG 
DIRECTOR
PARADIGM DIAGNOSTICS, INC.   |  MESA VERDE VENTURE PARTNERS III, L.P.   |  ELYSIUM THERAPEUTICS, INC.   |  MESA VERDE VENTURE PARTNERS IV, LP   |  MATRISYS BIOSCIENCE, INC.   |  IMMIX BIOPHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-12-04
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-16 
2018-07-03
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-16 
2017-12-11
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-16 
2016-12-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#